Gabriella M. Kastrunes

Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by Beta and Omicron variants

W. Marasco, Hanzhong Ke, Chiung-yu Huang, 2022, eBioMedicine.

Evolution of cell therapy for renal cell carcinoma

Ghanbar Mahmoodi Chalbatani, E. R. Suarez, Najla Santos Pacheco de Campos, 2024, Molecular cancer.

Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects

C. Paweletz, M. Ficial, B. Piel, 2024, Molecular cancer.

Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model

D. Braun, Aedin C. Culhane, Q. Zhu, 2024, iScience.

Abstract 886: Fine-tuned CAIX targeted CAR-T cells exhibit superior efficacy and mitigate on-target off-tumor side effects

C. Paweletz, Catherine J. Wu, S. Signoretti, 2023, Cancer Research.

Preclinical models for development of immune-oncology therapies.

W. Marasco, D. Barbie, S. Shelton, 2022, Immuno-oncology insights.

Abstract 2814: Anti-CAIX Immune Restoring (IR) CAR-T cells display superior antitumor activity and reverse immunosuppressive TME in a humanized ccRCC orthotopic mouse model

Kristen L Jones, C. Paweletz, S. Signoretti, 2022, Cancer Research.